BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16087013)

  • 1. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Murray JJ; Emparanza P; Lesinskas E; Tawadrous M; Breen JD
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
    Marple BF; Roberts CS; de Caprariis PJ; Reisman A
    Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study.
    Jorgensen DM
    Clin Microbiol Infect; 2009 Dec; 15(12):1103-10. PubMed ID: 19929975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
    Adelglass J; Jones TM; Ruoff G; Kahn JB; Wiesinger BA; Rielly-Gauvin K; Siu CO
    Pharmacotherapy; 1998; 18(6):1255-63. PubMed ID: 9855324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.
    Tribble DR; Sanders JW; Pang LW; Mason C; Pitarangsi C; Baqar S; Armstrong A; Hshieh P; Fox A; Maley EA; Lebron C; Faix DJ; Lawler JV; Nayak G; Lewis M; Bodhidatta L; Scott DA
    Clin Infect Dis; 2007 Feb; 44(3):338-46. PubMed ID: 17205438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Sydnor TA; Kopp EJ; Anthony KE; LoCoco JM; Kim SS; Fowler CL
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
    Klossek JM; Siegert R; Nikolaidis P; Arvis P; Leberre MA;
    J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC; Kapral D; Busman TA; Paris MM
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
    Anon JB; Paglia M; Xiang J; Ambrose PG; Jones RN; Kahn JB
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):105-7. PubMed ID: 17178300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a complex homeopathic medication (Sinfrontal) in patients with acute maxillary sinusitis: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Zabolotnyi DI; Kneis KC; Richardson A; Rettenberger R; Heger M; Kaszkin-Bettag M; Heger PW
    Explore (NY); 2007; 3(2):98-109. PubMed ID: 17362845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
    Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
    Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
    Gehanno P; Pessey JJ; Serrano E
    Med Mal Infect; 2005 Jun; 35(6):335-43. PubMed ID: 16023320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose azithromycin for the treatment of uncomplicated otitis media.
    Arguedas A; Loaiza C; Soley C
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S108-14. PubMed ID: 14770073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
    Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid.
    Brook I; Foote PA; Hausfeld JN
    Int J Antimicrob Agents; 2005 Nov; 26(5):416-9. PubMed ID: 16226017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial commentary: dilemma in trial design: do current study designs adequately evaluate effectiveness antibiotic in ABRS?
    Marple BF
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):200-1. PubMed ID: 16087014
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
    Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
    Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
    Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
    Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.